256 related articles for article (PubMed ID: 19013563)
1. Ovarian stimulation for fertility preservation in patients with cancer.
Quintero RB; Helmer A; Huang JQ; Westphal LM
Fertil Steril; 2010 Feb; 93(3):865-8. PubMed ID: 19013563
[TBL] [Abstract][Full Text] [Related]
2. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation.
Almog B; Azem F; Gordon D; Pauzner D; Amit A; Barkan G; Levin I
Fertil Steril; 2012 Oct; 98(4):957-60. PubMed ID: 22763097
[TBL] [Abstract][Full Text] [Related]
3. Women with cancer undergoing ART for fertility preservation: a cohort study of their response to exogenous gonadotropins.
Knopman JM; Noyes N; Talebian S; Krey LC; Grifo JA; Licciardi F
Fertil Steril; 2009 Apr; 91(4 Suppl):1476-8. PubMed ID: 18804204
[TBL] [Abstract][Full Text] [Related]
4. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
[TBL] [Abstract][Full Text] [Related]
5. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
[TBL] [Abstract][Full Text] [Related]
6. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation.
Huang JY; Tulandi T; Holzer H; Tan SL; Chian RC
Fertil Steril; 2008 Mar; 89(3):567-72. PubMed ID: 17543957
[TBL] [Abstract][Full Text] [Related]
7. Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges.
Gelbaya TA; Nardo LG; Fitzgerald CT; Horne G; Brison DR; Lieberman BA
Fertil Steril; 2006 May; 85(5):1464-8. PubMed ID: 16580673
[TBL] [Abstract][Full Text] [Related]
8. Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation.
McLaren JF; Burney RO; Milki AA; Westphal LM; Dahan MH; Lathi RB
Fertil Steril; 2009 Aug; 92(2):515-9. PubMed ID: 18829004
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience.
Oktay K; Oktem O
Fertil Steril; 2010 Feb; 93(3):762-8. PubMed ID: 19013568
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
11. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
12. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
[TBL] [Abstract][Full Text] [Related]
13. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
14. Techniques for fertility preservation in patients with breast cancer.
Dunn L; Fox KR
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):68-73. PubMed ID: 19125006
[TBL] [Abstract][Full Text] [Related]
15. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification.
Shalom-Paz E; Almog B; Shehata F; Huang J; Holzer H; Chian RC; Son WY; Tan SL
Reprod Biomed Online; 2010 Oct; 21(4):566-71. PubMed ID: 20822957
[TBL] [Abstract][Full Text] [Related]
16. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification.
Sánchez-Serrano M; Crespo J; Mirabet V; Cobo AC; Escribá MJ; Simón C; Pellicer A
Fertil Steril; 2010 Jan; 93(1):268.e11-3. PubMed ID: 19880105
[TBL] [Abstract][Full Text] [Related]
17. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval.
Raziel A; Schachter M; Strassburger D; Kasterstein E; Ron-El R; Friedler S
Fertil Steril; 2006 Sep; 86(3):583-7. PubMed ID: 16828475
[TBL] [Abstract][Full Text] [Related]
18. Fertility preservation for female cancer patients: early clinical experience.
Klock SC; Zhang JX; Kazer RR
Fertil Steril; 2010 Jun; 94(1):149-55. PubMed ID: 19406395
[TBL] [Abstract][Full Text] [Related]
19. Ovarian response in women undergoing ovarian stimulation after myomectomy.
Browne H; McCarthy-Keith D; Stegmann B; Spies J; Armstrong A
Fertil Steril; 2008 Nov; 90(5):2004.e19-21. PubMed ID: 18565518
[TBL] [Abstract][Full Text] [Related]
20. Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study.
Weiss A; Neril R; Geslevich J; Lavee M; Beck-Fruchter R; Golan J; Shalev E
Fertil Steril; 2014 Aug; 102(2):419-23. PubMed ID: 24880653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
